Evidence map›Paper›PMID 39770891›Full record

ReviewNutrients2024

Comparative Absorption and Bioavailability of Various Chemical Forms of Zinc in Humans: A Narrative Review.

Prasad P Devarshi, Qingqing Mao, Ryan W Grant, Susan Hazels Mitmesser

Abstract readReviewComparative Study
In one paragraph

Review in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Bioaccessibility of metals in food supplements: protocols and facts.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Zinc sulfate modulates the C3H10T1/2 mesenchymal stem cell line secretome and NFκB signaling during inflammation to influence selected immune cell responses.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Assessment of Zinc Content in Food Supplements.Foods (Basel, Switzerland) · 2026
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Prasad P DevarshiScience and Technology, Pharmavite, LLC, West Hills, CA 91304, USA.
Qingqing MaoScience and Technology, Pharmavite, LLC, West Hills, CA 91304, USA.
Ryan W GrantScience and Technology, Pharmavite, LLC, West Hills, CA 91304, USA.
Susan Hazels MitmesserScience and Technology, Pharmavite, LLC, West Hills, CA 91304, USA.ORCID 0000-0001-6353-1763

Funding

Pharmavite, LLC N/A
6 · The paper itself

Abstract

Zinc is an essential micronutrient that is needed for numerous critical health functions in the body. It is estimated that 17 to 20% of the global population is at risk for zinc deficiency, with certain groups at higher risk. The provision of supplemental zinc is a convenient and effective option for treating zinc deficiency and maintaining healthy levels of zinc. Several zinc salts are available for use in supplements. However, little information is available comparing the absorption and bioavailability of these different chemical forms of zinc. In this narrative review, we provide an overview of zinc absorption and bioavailability, discuss indicators of zinc status and risk factors for zinc deficiency, and review clinical studies comparing the absorption and bioavailability of different chemical forms of zinc in humans. This review of the clinical evidence suggests that zinc glycinate and zinc gluconate are better absorbed than other forms of zinc.

Indexed as

Biological AvailabilityDietary SupplementsZincGluconatesGlycineHumansIntestinal AbsorptionNutritional StatusGluconatesgluconic acidGlycineZincdietary supplementszinc citratezinc gluconatezinc glycinatezinc oxidezinc sulfate

Identifiers

PMID39770891
PMCPMC11677333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.